Submitted by Anonymous (not verified) on 19 October 2026 - 11:24
Human medicines European public assessment report (EPAR): Baiama, aflibercept, Date of authorisation: 13/01/2025, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Baiama, aflibercept, Date of authorisation: 13/01/2025, Revision: 5, Status: Authorised